Homology Medicines Presents on Design of pheEDIT Trial Evaluating One-Time Nuclease-Free Gene Editing Candidate HMI-103 for PKU at American Society of Human Genetics Meeting

Stock Information for Homology Medicines Inc.

Loading

Please wait while we load your information from QuoteMedia.